首站-论文投稿智能助手
典型文献
MicroRNAs as potential therapeutic targets for pancreatic cancer
文献摘要:
Pancreatic cancer is one of the most aggressive malignancies. The poor prognosis of pancreatic cancer patients is mainly attributed to low diagnostic rate at the early stage, highly aggressive nature coupled with the inadequate efficacy of current chemotherapeutic regimens. Novel therapeutic strategies are urgently needed for pancreatic cancer. MicroRNAs (miRNAs) play an important regulatory role in key processes of cancer development. The aberrant expression of miRNAs is often involved in the initiation, progression, and metastasis of pancreatic cancer. The discovery of tumor suppressor miRNAs provides prospects for the development of a novel treatment strategy for pancreatic cancer. We reviewed recent progress on the understanding of the role of miRNAs in pancreatic cancer, highlighted the efficient application of miRNAs-based therapies for pancreatic cancer in animal models and clinical trials, and proposed future prospects. This review focuses on the promise of integrating miRNAs into the treatment of pancreatic cancer and provides guidance for the development of precision medicine for pancreatic cancer.
文献关键词:
Pancreatic cancer;MicroRNA;MicroRNA carriers;Precision medicine
作者姓名:
Chu Xiangyu;Wei Dan;Liu Xinxin;Long Di;Tian Xiaodong;Yang Yinmo
作者机构:
Department of General Surgery, Peking University First Hospital, Beijing 100034, China
引用格式:
[1]Chu Xiangyu;Wei Dan;Liu Xinxin;Long Di;Tian Xiaodong;Yang Yinmo-.MicroRNAs as potential therapeutic targets for pancreatic cancer)[J].中华医学杂志(英文版),2022(01):4-10
A类:
B类:
MicroRNAs,potential,targets,pancreatic,cancer,Pancreatic,one,most,aggressive,malignancies,poor,prognosis,patients,mainly,attributed,low,diagnostic,early,stage,highly,nature,coupled,inadequate,efficacy,current,chemotherapeutic,regimens,Novel,strategies,are,urgently,needed,miRNAs,play,important,regulatory,role,key,processes,development,aberrant,expression,often,involved,initiation,progression,metastasis,discovery,tumor,suppressor,provides,prospects,novel,treatment,strategy,We,reviewed,recent,understanding,highlighted,efficient,application,therapies,animal,models,clinical,trials,proposed,future,This,focuses,promise,integrating,into,guidance,precision,medicine,carriers,Precision
AB值:
0.54901
相似文献
Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma
Duo Zuo;Yongzi Chen;Xinwei Zhang;Zhuozhi Wang;Wenna Jiang;Fan Tang;Runfen Cheng;Yi Sun;Lu Sun;Li Ren;Rui Liu-Department of Clinical Laboratory;Department of Tumor Cell Biology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Biomedical Engineering,Tianjin Medical University,Tianjin 300070,China;Department of Pathology,Tianjin Huanhu Hospital,Tianjin 300350,China;Department of Pathology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Pharmacy,Tianjin Medical University,Tianjin 300070,China;Department of Gastrointestinal Medical Oncology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China
Deficient Rnf43 potentiates hyperactive Kras-mediated pancreatic preneoplasia initiation and malignant transformation
Xian Zhou;Zhichao Sun;Mengdi Zhang;Xiaoyu Qu;Shuhui Yang;Lianmei Wang;Yanling Jing;Li Li;Weiwei Deng;Fangming Liu;Jin Di;Jie Chen;Jian Wu;Hongbing Zhang-State Key Laboratory of Medical Molecular Biology,Department of Physiology,Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing, China;Institute of Cancer Stem Cell,Dalian Medical University,Dalian,China;Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences,Beijing,China;Department of Pathology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences,Beijing, China;MyGenostics Inc.,Beijing,China
Acquisition of taxane resistance by p53 inactivation in ovarian cancer cells
Changfa Shu;Xi Zheng;Alafate Wuhafu;Danielle Cicka;Sean Doyle;Qiankun Niu;Dacheng Fan;Kun Qian;Andrey A.Ivanov;Yuhong Du;Xiulei Mo;Haian Fu-Department of Pharmacology and Chemical Biology,Emory University School of Medicine,Atlanta,GA 30322,USA;Department of Gynecology and Obstetrics,The Third Xiangya Hospital of Central South University,Changsha 410013,China;Cancer Institute,the Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310052,China;The First Affiliated Hospital,Medical School of Xi'an Jiaotong University,Xi'an 710061,China;Emory Chemical Biology Discovery Center,Emory University School of Medicine,Atlanta,GA 30322,USA;Department of Hematology and Medical Oncology and Winship Cancer Institute,Emory University,Atlanta,GA 30322,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。